From BGI Genomics Mar 31 2026 Intrahepatic cholangiocarcinoma (iCCA), the second most common primary liver cancer after hepatocellular carcinoma, remains one of the most challenging malignancies to treat due to its highly concealed and heterogeneous nature. A collaborative team from BGI Genomics and Zhongshan Hospital of Fudan University has now charted the molecular “chaos” of iCCA, providing a navigational framework for more precise diagnosis and treatment. The  research is published in Cell